Literature DB >> 18190370

Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial [ISRCTN22532458].

C Nagle1, J Gunn, R Bell, S Lewis, B Meiser, S Metcalfe, O C Ukoumunne, J Halliday.   

Abstract

OBJECTIVE: To evaluate the effectiveness of a decision aid for prenatal testing of fetal abnormalities compared with a pamphlet in supporting women's decision making.
DESIGN: A cluster randomised controlled trial.
SETTING: Primary health care. POPULATION: Women in early pregnancy consulting a GP.
METHODS: GPs were randomised to provide women with either a decision aid or a pamphlet. The decision aid was a 24-page booklet designed using the Ottowa Decision Framework. The pamphlet was an existing resource available in the trial setting. MAIN OUTCOME MEASURES: Validated scales were used to measure the primary outcomes, informed choice and decisional conflict, and the secondary outcomes, anxiety, depression, attitudes to the pregnancy/fetus and acceptability of the resource. Outcomes were measured at 14 weeks of gestation from questionnaires that women completed and returned by post.
FINDINGS: Women in the intervention group were more likely to make an informed decision 76% (126/165) than those in the control group 65% (107/165) (adjusted OR 2.08; 95% CI 1.14-3.81). A greater proportion of women in the intervention group 88% (147/167) had a 'good' level of knowledge than those in the control group 72% (123/171) (adjusted OR 3.43; 95% CI 1.79-6.58). Mean (SD) decisional conflict scores were low in both groups, decision aid 1.71 (0.49), pamphlet 1.65 (0.55) (adjusted mean difference 0.10; 95% CI -0.02 to 0.22). There was no strong evidence of differences between the trial arms in the measures of psychological or acceptability outcomes.
CONCLUSION: A tailored prenatal testing decision aid plays an important role in improving women's knowledge of first and second trimester screening tests and assisting them to make decisions about screening and diagnostic tests that are consistent with their values.

Entities:  

Mesh:

Year:  2008        PMID: 18190370     DOI: 10.1111/j.1471-0528.2007.01576.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  23 in total

Review 1.  Measuring informed choice in population-based reproductive genetic screening: a systematic review.

Authors:  Alice Grace Ames; Sylvia Ann Metcalfe; Alison Dalton Archibald; Rony Emily Duncan; Jon Emery
Journal:  Eur J Hum Genet       Date:  2014-05-21       Impact factor: 4.246

2.  The effect of a decision aid on informed decision-making in the era of non-invasive prenatal testing: a randomised controlled trial.

Authors:  Lean Beulen; Michelle van den Berg; Brigitte Hw Faas; Ilse Feenstra; Michiel Hageman; John Mg van Vugt; Mireille N Bekker
Journal:  Eur J Hum Genet       Date:  2016-05-18       Impact factor: 4.246

3.  It's complicated - Factors predicting decisional conflict in prenatal diagnostic testing.

Authors:  Cécile Muller; Linda D Cameron
Journal:  Health Expect       Date:  2015-04-13       Impact factor: 3.377

4.  Talking Points: Women's Information Needs for Informed Decision-Making About Noninvasive Prenatal Testing for Down Syndrome.

Authors:  Aimée C Dane; Madelyn Peterson; Yvette D Miller
Journal:  J Genet Couns       Date:  2018-03-17       Impact factor: 2.537

Review 5.  Personalised risk communication for informed decision making about taking screening tests.

Authors:  Adrian G K Edwards; Gurudutt Naik; Harry Ahmed; Glyn J Elwyn; Timothy Pickles; Kerry Hood; Rebecca Playle
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.

Authors:  Alice G Ames; Alice Jaques; Obioha C Ukoumunne; Alison D Archibald; Rony E Duncan; Jon Emery; Sylvia A Metcalfe
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

7.  A randomized trial of a prenatal genetic testing interactive computerized information aid.

Authors:  Lynn M Yee; Michael Wolf; Rebecca Mullen; Ashley R Bergeron; Stacy Cooper Bailey; Robert Levine; William A Grobman
Journal:  Prenat Diagn       Date:  2014-03-18       Impact factor: 3.050

8.  Spanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections.

Authors:  Erin Floyd; Megan A Allyse; Marsha Michie
Journal:  J Genet Couns       Date:  2016-01-07       Impact factor: 2.537

9.  Evaluation of a Mammography Screening Decision Aid for Women Aged 75 and Older: Protocol for a Cluster-randomized Controlled Trial.

Authors:  Mara A Schonberg; Christine E Kistler; Larissa Nekhlyudov; Angela Fagerlin; Roger B Davis; Christina C Wee; Edward R Marcantonio; Carmen L Lewis; Whitney A Stanley; Trisha M Crutchfield; Mary Beth Hamel
Journal:  J Clin Trials       Date:  2014

10.  Evaluation of a theory-informed implementation intervention for the management of acute low back pain in general medical practice: the IMPLEMENT cluster randomised trial.

Authors:  Simon D French; Joanne E McKenzie; Denise A O'Connor; Jeremy M Grimshaw; Duncan Mortimer; Jill J Francis; Susan Michie; Neil Spike; Peter Schattner; Peter Kent; Rachelle Buchbinder; Matthew J Page; Sally E Green
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.